Diagenode Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 135

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $159M

Diagenode General Information

Description

Developer of an innovative technology platform intended to offer epigenetics research, biological sample preparation and diagnostics assays. The company's innovative technology platform offers innovative Bioruptor shearing and IP-Star automation instruments, reagent kits and quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows, enabling clients to avail premium products.

Contact Information

Website
www.diagenode.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Diagnostic Equipment
Parent Company
Hologic
Primary Office
  • Rue Bois Saint-Jean, 3
  • 4102 Seraing
  • Belgium
+32 04 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diagenode Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Mar-2021 $159M 00.000 00000 Completed Generating Revenue
3. Later Stage VC 20-Jun-2016 00.000 00.000 Completed Generating Revenue
2. Debt - General 01-Jan-2016 $1.52M $7.45M Completed Generating Revenue
1. Early Stage VC 04-Apr-2015 $5.93M $5.93M 000.00 Completed Generating Revenue
To view Diagenode’s complete valuation and funding history, request access »

Diagenode Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class B 0,000 00000.00 00000.00 00 00000.00 00.000
Class A 000 0000.00 0000.00 00 0000.00 0.000
To view Diagenode’s complete cap table history, request access »

Diagenode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an innovative technology platform intended to offer epigenetics research, biological sample preparation and
Biotechnology
Seraing, Belgium
135 As of 2021
00.000
0000 0000-00-00
000000&0 00.000

000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000 000000000
San Diego, CA
0000 As of 0000
00.000
0000 00.000

000000

llum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
0000000000000
Woburn, MA
000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Diagenode Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA 0000 00.000 0000 00.000
0000000 Private Equity-Backed Woburn, MA 000 000.00 000000000 000.00
000000000 Corporation Farmingdale, NY 00 000000000 -
000000000 0000 Private Equity-Backed Pleasanton, CA 000 00.000 000000000 00.000
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
You’re viewing 5 of 31 competitors. Get the full list »

Diagenode Patents

  • 14

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Diagenode Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3828283-A1 An improved sequencing method and kit Inactive 28-Nov-2019 00000000000 00
EP-3798319-A1 An improved diagnostic and/or sequencing method and kit Pending 30-Sep-2019 0000000000 00
US-20210095339-A1 Diagnostic and/ or sequencing method and kit Pending 30-Sep-2019 0000000000 0
EP-3798318-A1 A high throughput sequencing method and kit Inactive 30-Sep-2019 0000000000 0
EP-3947721-A1 A high throughput sequencing method and kit Pending 27-Mar-2019 C12Q1/6806
To view Diagenode’s complete patent history, request access »

Diagenode Executive Team (7)

Name Title Board Seat Contact Info
Didier Allaer Founder & Chief Executive Officer
Dab Gilespie Chief Financial Officer
Rini Saxena Vice President, Marketing and Commercialization
Rosemarie Koster Vice President of Administration and Human Resources
You’re viewing 4 of 7 executive team members. Get the full list »

Diagenode Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diagenode Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capricorn Partners Venture Capital Minority 000 0000 000000 0
Epimède Venture Capital Minority 000 0000 000000 0
Noshaq PE/Buyout Minority 000 0000 000000 0
Ostbelgieninvest Venture Capital Minority 000 0000 000000 0
Société Régionale d'Investissement de Wallonie Growth/Expansion Minority 000 0000 000000 0
To view Diagenode’s complete investors history, request access »

Diagenode Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000-00 16-Aug-2018 0000000000 Biotechnology 000000 00
To view Diagenode’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Diagenode Subsidiaries (1)

Company Name Industry Location Founded
000-00 Biotechnology Ghent, Belgium 0000
To view Diagenode’s complete subsidiaries history, request access »